Diagnostic and prognostic value of alpha-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study.
Orrú CD, Vaughan DP, Vijiaratnam N, Real R, Martinez-Carrasco A, Fumi R, Jensen MT, Hodgson M, Girges C, Gil-Martinez AL, Stafford EJ, Wu L, Lerche S, Wurster I, Groveman BR, Hughson AG, Ansorge O, Quaegebeur A, Allinson KSJ, Warner TT, Jaunmuktane Z, Misbahuddin A, Leigh PN, Ghosh BCP, Bhatia KP, Church A, Kobylecki C, Hu MTM, Rowe JB, Parchi P, Brockmann K, Foltynie T, Morris HR, Caughey B, Jabbari E.
Orrú CD, et al.
Lancet Neurol. 2025 Jul;24(7):580-590. doi: 10.1016/S1474-4422(25)00157-7.
Lancet Neurol. 2025.
PMID: 40541208
Free article.
We compared seeding kinetic measures between sporadic Parkinson's disease and progressive supranuclear palsy, and between sporadic Parkinson's disease and monogenic Parkinson's disease. ...TTT was faster in GBA1-associated Parkinson's disease compared …
We compared seeding kinetic measures between sporadic Parkinson's disease and progressive supranuclear palsy, and between sporadic Pa …